We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Arrowhead Nanobiotechnology Subisidaries, Calando and Insert Complete Merger

News   Apr 25, 2008

 
Arrowhead Nanobiotechnology Subisidaries, Calando and Insert Complete Merger
 
 
 

RELATED ARTICLES

The "Midlife Crisis" of Molecular Aging

News

Key molecular programs known to promote longevity do not last beyond midlife, according to a study of genomic patterns in human muscle and brain tissue. The study suggests a possible explanation for why the human disease burden increases so sharply from the sixth decade of life.

READ MORE

tRNA a Warning System for Oncoming Epileptic Seizures?

News

Changes in the concentration of specific transfer RNAs, a major class of noncoding RNA, are associated with epilepsy. The findings suggest that tRNA fragments could serve as an early warning system for predicting seizure risk.

READ MORE

New Strategy for Producing Targeted Therapies Against Cancer and Neurodegeneration

News

A new study highlights a novel strategy for drug discovery and development that can be used to produce targeted therapies against diseases such as cancer and neurodegeneration. It is hoped that the process will also be useful in the large-scale production of new pharmaceuticals.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE